NAC1 is significantly overexpressed in several carcinoma types, including ovarian, colorectal, breast, renal cell, cervical, and pancreatic carcinomas, and is associated with tumor growth and survival via resistance to platinum-based chemotherapy [13,14,15,16,17,18,19,20,21,22,23]. Here, NACC1 is linked to neoplasm.